The use of ethanol in paediatric formulations in New Zealand

Darren Svirskis1, Meiyen Toh, Sanyogita Ram

  • 1School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. d.svirskis@auckland.ac.nz

Insights

Ethanol is present in many children's liquid medicines in New Zealand, with concerningly high concentrations in some. Clearer labelling is needed globally to ensure safe medicine choices for pediatric patients.

Area of Science:

  • Pharmaceutical Science
  • Paediatric Medicine
  • Public Health

Background:

  • Ethanol is commonly used in paediatric liquid medicines as a solvent and preservative.
  • Safety concerns exist regarding both acute and chronic ethanol exposure in children.
  • Cultural and religious factors may preclude ethanol use for some families.

Purpose of the Study:

  • To investigate the availability of ethanol-containing medicines for paediatric use in New Zealand.
  • To compare findings with international guidelines on ethanol in paediatric medicines.

Main Methods:

  • Identification of paediatric liquid medicines available in New Zealand.
  • Analysis of ethanol content in identified medicinal products.

Main Results:

  • Forty-seven paediatric liquid medicines containing ethanol were identified.
  • Ethanol concentrations ranged from 0.6% to 76% v/v.
  • Some medicines, like digoxin (10.1-11.4% v/v ethanol), are used in neonates.

Conclusions:

  • Stricter guidance is necessary to reduce ethanol use in paediatric medicines, both in New Zealand and globally.
  • Full disclosure of ethanol presence and concentration on labels is crucial for informed decision-making by healthcare professionals and patients.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Ethers from Alcohols: Alcohol Dehydration and Williamson Ether Synthesis02:29

Ethers from Alcohols: Alcohol Dehydration and Williamson Ether Synthesis

Overview
Ethers can be prepared from organic compounds by various methods. Some of them are discussed below,
Preparation of Ethers by Alcohol Dehydration
In this method, in the presence of protic acids, alcohol dehydrates to produce alkenes and ethers under different conditions. For example, in the presence of sulphuric acid, dehydration of ethanol at 413 K yields ethoxyethane, whereas it yields ethene at 443 K.